Results 141 to 150 of about 43,229 (277)

123 EFFICACY AND SAFETY OF AN INTENSIFIED REGIMEN OF PEGYLATED INTERFERON ALFA-2A PLUS RIBAVIRIN IN HCV GENOTYPE 1 NON-RESPONDERS: AN INTERIM ANALYSIS OF THE SYREN TRIAL

, 2009
C. Hézode, Juliette Foucher, J.‐P. Bronowicki, Valériane Leroy, Albert Tran, Dominique Larrey, Philippe Mathurin, Isabelle Rosa, Laurent Alric, Valérie Dhalluin-Venier, Abdelbasset Nani, Magali Bouvier‐Alias, Stéphanie Rouanet, Patrice Couzigou, A. Mallat, Mariem Charafeddine, Jean–Michel Pawlotsky   +16 more
openalex   +1 more source

Efficacy of pegylated interferon and ribavirin for retreatment of chronic HCV infection in HIV co-infected patients failing a previous standard interferon-based regimen [PDF]

, 2008
Manuel Crespo, J. A. Mira, Juan A. Pineda, Eva Van den Eynde, Maria José Ríos-Villegas, Antonio Collado, J.A. Girón González, Luís F. López‐Cortés, Mercedes González‐Serrano, Antonio Rivero, Dolores Merino, Rafael Esteban   +11 more
openalex   +1 more source

Impact of Non‐Alcoholic Fatty Liver Disease on the HBsAg Loss of Patients With Chronic Hepatitis B Treated in Pegylated Interferon Alpha [PDF]

Chujing Li, Lihua Lin, Pei Zhou, Haiyi Cai, Songlian Liu, Xiaohong Chen, Aiqi Lu, Bo Li, Yaping Wang, Chuanghua Luo, Jianping Li, Guan Yu-juan, Zhiwei Xie   +12 more
openalex   +1 more source

Acute psychosis after injection of pegylated interferon alpha-2a [PDF]

, 2003
Johannes Thome, Udo Knopf
openalex   +1 more source

Interferon (IFN)–γ–Inducible Protein–10: Association with Histological Results, Viral Kinetics, and Outcome during Treatment with Pegylated IFN‐α2a and Ribavirin for Chronic Hepatitis C Virus Infection [PDF]

, 2006
Ana I. Romero, Martin Lagging, Johan Westin, Amar P. Dhillon, Lynn B. Dustin, Jean–Michel Pawlotsky, Avidan U. Neumann, Carlo Ferrari, Gabriele Missale, Bart L. Haagmans, Solko W. Schalm, Stefan Zeuzem, Francesco Negro, Elke Verheij‐Hart, Kristoffer Hellstrand, DITTO‐HCV Study Group   +15 more
openalex   +1 more source

P11: Miravirsen does not interact with pegylated interferon‐alpha or ribavirin [PDF]

, 2013
Robert Matongo Persson, C. Wynne, Arthur A. Levin, Bruce L. King, Teresa Boyea, Karin Zeh, Michael R. Hodges   +6 more
openalex   +1 more source

NFB-07. USE OF PEGYLATED INTERFERON α- 2b IN PEDIATRIC PATIENTS AFFECTED BY UNRESECTABLE PLEXIFORM NEUROFIBROMAS: MONOCENTRIC EXPERIENCE [PDF]

, 2020
Antonella Cacchione, Mária Lódi, Giada Del Baldo, Andrea Carai, Giovanna Stefania Colafati, Francesca Diomedi‐Camassei, Franco Locatelli, Angela Mastronuzzi   +7 more
openalex   +1 more source

Rapid Hematological and Molecular Response to Pegylated Interferon in WHO-Defined Pre-Fibrotic Myelofibrosis. [PDF]

Cancers (Basel)
Machherndl-Spandl S, Kiehberger M, Sygulla V, Kaynak E, Zach O, Webersinke G, Gruber-Rossipal C, Beham-Schmid C, Maier E, Strassl I, Clausen J, Nikoloudis A, Schimetta W, Rumpold H, Buxhofer-Ausch V.   +14 more
europepmc   +1 more source

Safety evaluation and toxicokinetics of repeated inhalation exposure to pegylated interferon α-2b. [PDF]

Front Pharmacol
Ji C, Ji X, Li H, Wang Q.
europepmc   +1 more source

Statins enhance the efficacy of pegylated interferon-alfa2 in Philadelphia-negative chronic myeloproliferative neoplasms. [PDF]

Blood Adv
Davidsen ID, Larsen MK, Löffler L, Skov V, Kjær L, Knudsen TA, Sørensen AL, Christensen SF, Cordua S, Eickhardt-Dalbøge CS, Kristiansen MH, Ellervik C, Wienecke T, Hasselbalch HC.   +13 more
europepmc   +1 more source